Setting

Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity

Published: 28 Jul 2020 | Report Code: 10247612 | Pages: 104

Asia Pacific digital respiratory solutions market will grow by 41.6% annually with a total addressable market cap of $219.0 million over 2020-2030 owing to the rising demand for respiratory aids and air purification amid COVID-19 pandemic. Highlighted with 31 tables and 42 figures, this 104-page report “Asia Pacific Digital Respiratory Solutions Market 2020-2030 by Product Type, Indication (Asthma, COPD), Distribution Channel, and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific digital respiratory solutions market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific digital respiratory solutions market in every aspect of the classification from perspectives of Product Type, Indication, Distribution Channel, and Country. Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. Therapeutic Devices • Inhalers • Nebulizers Diagnostic Devices • Spirometers • Asthma Monitors • Other Diagnostic Devices Sensors and Apps Based on Indication, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Asthma • Chronic Obstructive Pulmonary Disease (COPD) • COVID-19 Caused Diseases • Other Diseases Based on Distribution Channel, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section. • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Geographically, the following national/local markets are fully investigated: • Japan • China • South Korea • Australia • India • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) For each aforementioned country, detailed analysis and data for annual revenue are available for 2019-2030. The breakdown of key national markets by Product Type, Indication, and Distribution Channel over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in Asia Pacific digital respiratory solutions market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players (this may not be a complete list and extra companies can be added upon request): 3M Health Care Limited Adherium Limited Amiko Digital Health Limited AsthmaMD AstraZeneca plc Boehringer Ingelheim International GmbH Capsule Technologies, Inc. Cohero Health GlaxoSmithKline plc Kaia Health Software GmbH Medical International Research (MIR) Novartis AG NuvoAir Reciprocal Labs (Propeller Health) Sensiron AG Tactio Health Teva Pharmaceuticals Industries Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) 

Table Of Contents

1 Introduction 5
1.1 Industry Definition and Research Scope 5
1.1.1 Industry Definition 5
1.1.2 Research Scope 6
1.2 Research Methodology 9
1.2.1 Overview of Market Research Methodology 9
1.2.2 Market Assumption 10
1.2.3 Secondary Data 10
1.2.4 Primary Data 10
1.2.5 Data Filtration and Model Design 12
1.2.6 Market Size/Share Estimation 13
1.2.7 Research Limitations 14
1.3 Executive Summary 15
2 Market Overview and Dynamics 17
2.1 Market Size and Forecast 17
2.1.1 Impact of COVID-19 on the Market 18
2.2 Major Growth Drivers 20
2.3 Market Restraints and Challenges 25
2.4 Emerging Opportunities and Market Trends 28
2.5 Porter’s Fiver Forces Analysis 32
3 Segmentation of Asia Pacific Market by Product Type 37
3.1 Market Overview by Product Type 37
3.2 Therapeutic Devices 39
3.2.1 Inhalers 40
3.2.2 Nebulizers 41
3.3 Diagnostic Devices 42
3.3.1 Spirometers 44
3.3.2 Asthma Monitors 45
3.3.3 Other Diagnostic Devices 46
3.4 Sensors and Apps 47
4 Segmentation of Asia Pacific Market by Indication 48
4.1 Market Overview by Indication 48
4.2 Asthma 50
4.3 Chronic Obstructive Pulmonary Disease (COPD) 51
4.4 COVID-19 Caused Diseases 52
4.5 Other Diseases 53
5 Segmentation of Asia Pacific Market by Distribution Channel 54
5.1 Market Overview by Distribution Channel 54
5.2 Hospital Pharmacies 56
5.3 Retail Pharmacies 57
5.4 Online Pharmacies 58
6 Asia-Pacific Market 2019-2030 by Country 59
6.1 Overview of Asia-Pacific Market 59
6.2 Japan 62
6.3 China 65
6.4 Australia 68
6.5 India 70
6.6 South Korea 72
6.7 Rest of APAC Region 74
7 Competitive Landscape 76
7.1 Overview of Key Vendors 76
7.2 New Product Launch, Partnership, Investment, and M&A 79
7.3 Company Profiles 80
3M Health Care Limited 80
Adherium Limited 82
Amiko Digital Health Limited 83
AsthmaMD 84
AstraZeneca plc 85
Boehringer Ingelheim International GmbH 86
Capsule Technologies, Inc. 87
Cohero Health 88
GlaxoSmithKline plc 89
Kaia Health Software GmbH 90
Medical International Research (MIR) 91
Novartis AG 92
NuvoAir 93
Reciprocal Labs (Propeller Health) 94
Sensiron AG 95
Tactio Health 96
Teva Pharmaceuticals Industries Ltd. 97
8 Investing in Asia Pacific Market: Risk Assessment and Management 98
8.1 Risk Evaluation of Asia Pacific Market 98
8.2 Critical Success Factors (CSFs) 101
Related Reports and Products 104

List Of Tables

Table 1.  Snapshot of Asia Pacific Digital Respiratory Solutions Market, 2019-2030 16
Table 2.  Main Product Trends and Market Opportunities in Asia Pacific Digital Respiratory Solutions Market 28
Table 3. Asia Pacific Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 37
Table 4. Asia Pacific Digital Respiratory Solutions Market: Therapeutic Devices by Type, 2019-2030, $ mn 39
Table 5. Asia Pacific Digital Respiratory Solutions Market: Diagnostic Devices by Type, 2019-2030, $ mn 43
Table 6. Asia Pacific Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 48
Table 7. Asia Pacific Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 54
Table 8. APAC Digital Respiratory Solutions Market by Country, 2019-2030, $ mn 60
Table 9. Japan Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 64
Table 10. Japan Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 64
Table 11. Japan Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 64
Table 12. China Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 67
Table 13. China Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 67
Table 14. China Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 67
Table 15. Australia Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 69
Table 16. Australia Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 69
Table 17. Australia Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 69
Table 18. India Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 71
Table 19. India Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 71
Table 20. India Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 71
Table 21. South Korea Digital Respiratory Solutions Market by Product Type, 2019-2030, $ mn 73
Table 22. South Korea Digital Respiratory Solutions Market by Indication, 2019-2030, $ mn 73
Table 23. South Korea Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, $ mn 73
Table 24. Digital Respiratory Solutions Market in Rest of APAC by Country, 2019-2030, $ mn 75
Table 25. 3M Health Care Limited: Company Snapshot 80
Table 26. 3M Health Care Limited: Business Segmentation 80
Table 27. 3M Health Care Limited: Product Portfolio 81
Table 28. 3M Health Care Limited: Revenue, 2016-2018, $ mn 81
Table 29. 3M Health Care Limited: Recent Developments 81
Table 30.  Risk Evaluation for Investing in Asia Pacific Market, 2019-2030 99
Table 31. Critical Success Factors and Key Takeaways 102

List Of Figures

Figure 1. Research Method Flow Chart 9
Figure 2. Breakdown of Primary Research 11
Figure 3. Bottom-up Approach and Top-down Approach for Market Estimation 13
Figure 4. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030 15
Figure 5. Asia Pacific Digital Respiratory Solutions Market, 2019-2030, $ mn 17
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Digital Respiratory Solutions Market 20
Figure 7. GDP per capita in the World, 1960-2018, $ thousand 23
Figure 8. Forecast of Middle-class Population by Region, 2015-2030, million 23
Figure 9. Worldwide Connected Devices by Device Type, 2014-2022, billion units 24
Figure 10. Primary Restraints and Impact Factors of Asia Pacific Digital Respiratory Solutions Market 25
Figure 11. Investment Opportunity Analysis 29
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific Digital Respiratory Solutions Market 32
Figure 13. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Product Type, 2019-2030, % of Sales Revenue 37
Figure 14. Asia Pacific Addressable Market Cap in 2020-2030 by Product Type, Value ($ mn) and Share (%) 38
Figure 15. Asia Pacific Digital Respiratory Solutions Market: Therapeutic Devices, 2019-2030, $ mn 39
Figure 16. Asia Pacific Digital Respiratory Solutions Market: Inhalers, 2019-2030, $ mn 40
Figure 17. Asia Pacific Digital Respiratory Solutions Market: Nebulizers, 2019-2030, $ mn 41
Figure 18. Asia Pacific Digital Respiratory Solutions Market: Diagnostic Devices, 2019-2030, $ mn 42
Figure 19. Asia Pacific Digital Respiratory Solutions Market: Spirometers, 2019-2030, $ mn 44
Figure 20. Asia Pacific Digital Respiratory Solutions Market: Asthma Monitors, 2019-2030, $ mn 45
Figure 21. Asia Pacific Digital Respiratory Solutions Market: Other Diagnostic Devices, 2019-2030, $ mn 46
Figure 22. Asia Pacific Digital Respiratory Solutions Market: Sensors and Apps, 2019-2030, $ mn 47
Figure 23. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Indication, 2019-2030, % of Sales Revenue 49
Figure 24. Asia Pacific Addressable Market Cap in 2020-2030 by Indication, Value ($ mn) and Share (%) 49
Figure 25. Asia Pacific Digital Respiratory Solutions Market: Asthma, 2019-2030, $ mn 50
Figure 26. Asia Pacific Digital Respiratory Solutions Market: Chronic Obstructive Pulmonary Disease (COPD), 2019-2030, $ mn 51
Figure 27. Asia Pacific Digital Respiratory Solutions Market: COVID-19 Caused Diseases, 2019-2030, $ mn 52
Figure 28. Asia Pacific Digital Respiratory Solutions Market: Other Diseases, 2019-2030, $ mn 53
Figure 29. Breakdown of Asia Pacific Digital Respiratory Solutions Market by Distribution Channel, 2019-2030, % of Revenue 55
Figure 30. Asia Pacific Addressable Market Cap in 2020-2030 by Distribution Channel, Value ($ mn) and Share (%) 55
Figure 31. Asia Pacific Digital Respiratory Solutions Market: Hospital Pharmacies, 2019-2030, $ mn 56
Figure 32. Asia Pacific Digital Respiratory Solutions Market: Retail Pharmacies, 2019-2030, $ mn 57
Figure 33. Asia Pacific Digital Respiratory Solutions Market: Online Pharmacies, 2019-2030, $ mn 58
Figure 34. Breakdown of APAC Digital Respiratory Solutions Market by Country, 2019 and 2030, % of Revenue 60
Figure 35. Contribution to APAC 2020-2030 Cumulative Revenue by Country, Value ($ mn) and Share (%) 61
Figure 36.  Digital Respiratory Solutions Market in Japan, 2019-2030, $ mn 63
Figure 37.  Digital Respiratory Solutions Market in China, 2019-2030, $ mn 66
Figure 38.  Digital Respiratory Solutions Market in Australia, 2019-2030, $ mn 68
Figure 39.  Digital Respiratory Solutions Market in India, 2019-2030, $ mn 70
Figure 40.  Digital Respiratory Solutions Market in South Korea, 2019-2030, $ mn 72
Figure 41.  Digital Respiratory Solutions Market in Rest of APAC, 2019-2030, $ mn 74
Figure 42. Growth Stage of Asia Pacific Digital Respiratory Solutions Industry over the Forecast Period 76


Key Players (this may not be a complete list and extra companies can be added upon request): 
3M Health Care Limited 
Adherium Limited 
Amiko Digital Health Limited 
AsthmaMD 
AstraZeneca plc 
Boehringer Ingelheim International GmbH 
Capsule Technologies, Inc. 
Cohero Health 
GlaxoSmithKline plc 
Kaia Health Software GmbH 
Medical International Research (MIR) 
Novartis AG 
NuvoAir 
Reciprocal Labs (Propeller Health) 
Sensiron AG 
Tactio Health 
Teva Pharmaceuticals Industries Ltd.